Suppr超能文献

新型口服头孢菌素抗生素头孢克洛的稳定性及血药浓度测定

Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

作者信息

Foglesong M A, Lamb J W, Dietz J V

出版信息

Antimicrob Agents Chemother. 1978 Jan;13(1):49-52. doi: 10.1128/AAC.13.1.49.

Abstract

Cefaclor solutions in pH 2.5 and 4.5 buffers contained at least 90% of their initial activity after 72 h at 4 degrees C. Samples in pH 6.0, 7.0, and 8.0 buffers contained 70, 46, and 34%, respectively, of their initial activity after 72 h at 4 degrees C. After 72 h at 25 degrees C, samples prepared with pH 2.5, 4.5, 6.0, 7.0, and 8.0 buffers contained 95, 69, 16, 5, and 3%, respectively, of their initial activity. After 72 h at 37 degrees C, cefaclor solutions in pH 2.5 buffer contained 80% of the initial activity, whereas samples prepared in pH 4.5, 6.0, 7.0, and 8.0 buffers contained less than 20%. Laboratory-prepared plasma and serum samples showed an 8% loss in activity when incubated for 6 h at 4 degrees C, a 51% loss when incubated for 6 h at 25 degrees C, and a 48% loss when incubated for 2 h at 37 degrees C. Clinical samples demonstrated a similar stability pattern. Degradation rates for cefaclor in commercially prepared serum increased from 4- to 10-fold in comparison to rates obtained when samples were made in human serum freshly prepared in our laboratory. Consequently, serum standards should be made in freshly prepared human serum.

摘要

头孢克洛溶液在pH 2.5和4.5缓冲液中于4℃放置72小时后,其初始活性至少保留90%。在pH 6.0、7.0和8.0缓冲液中的样品于4℃放置72小时后,分别保留其初始活性的70%、46%和34%。在25℃放置72小时后,用pH 2.5、4.5、6.0、7.0和8.0缓冲液制备的样品分别保留其初始活性的95%、69%、16%、5%和3%。在37℃放置72小时后,pH 2.5缓冲液中的头孢克洛溶液保留80%的初始活性,而在pH 4.5、6.0、7.0和8.0缓冲液中制备的样品保留率低于20%。实验室制备的血浆和血清样品在4℃孵育6小时后活性损失8%,在25℃孵育6小时后损失51%,在37℃孵育2小时后损失48%。临床样品表现出类似的稳定性模式。与在我们实验室新鲜制备的人血清中制备样品的降解率相比,市售血清中头孢克洛的降解率增加了4至10倍。因此,血清标准品应在新鲜制备的人血清中制备。

相似文献

7
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
J Clin Hosp Pharm. 1986 Feb;11(1):47-54. doi: 10.1111/j.1365-2710.1986.tb00827.x.

引用本文的文献

4
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
Eur J Clin Microbiol. 1987 Oct;6(5):570-1. doi: 10.1007/BF02014248.
5
In vitro activities of LY163892, cefaclor, and cefuroxime.LY163892、头孢克洛和头孢呋辛的体外活性。
Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131.
10
[Investigations on the excretion of cefaclor in human bile (author's transl)].
Infection. 1979;7 Suppl 6:624-7. doi: 10.1007/BF01659752.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验